Class summary at a glance.

Every drug in the Sulfonamide Antibacterial class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 3tracked in Part D
CY24 Part D spend: $16.6Mcombined across class
Total Rx claims: 934K620K unique beneficiaries
Generic mfrs (active): 1across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Silver Sulfadiazine

Brand: SILVADENE · 933K Part D claims (CY24) · 620K beneficiaries · First FDA approval: 1973-11-26

Brand-only (no generics) 0 plans require PA

Low NADAC$0.110

→

Avg plan cost$0.250

Part D spend $15.4M 2× spread, current vs floor

Class share

93%

of class CY24 spend

View profile →

Sulfadiazine

762 Part D claims (CY24) · 303 beneficiaries · First FDA approval: 2021-12-15

1 generic mfrs 0 plans require PA

Low NADAC$14.98

→

Avg plan cost$14.98

Part D spend $1.2M 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Sodium Sulfacetamide, Sulfur

Brand: SODIUM SULFACETAMIDE - SULFUR WASH · — Part D claims (CY24) · First FDA approval: 2010-09-16

Brand-only (no generics)

Low NADAC$0.230

→

Avg plan cost$0.230

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.